K101-03 治疗中的早期可见改善:一项针对甲真菌病和/或甲银屑病患者的开放性多中心临床研究。
Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis.
机构信息
Department of Experimental, Diagnostic and Specialty Medicine, Università di Bologna, Bologna, Italy.
出版信息
Dermatology. 2017;233(2-3):178-183. doi: 10.1159/000478257. Epub 2017 Aug 5.
INTRODUCTION
Onychomycosis and nail psoriasis can be embarrassing to patients, so improving the appearance of affected nails should be one of the key short-term goals of treatment.
METHODS
An 8-week open-label multicenter study was conducted to assess whether K101-03, a marketed topical treatment containing propylene glycol, glycerol, urea, and lactic acid, could produce rapid cosmetic improvements in affected nails. Adult patients with a big toenail or thumbnail (the "target" nail) affected by onychomycosis (n = 72) or psoriasis (n = 34) or both (n = 1) applied K101-03 to their affected nails once a day for 8 weeks. During and after treatment, patients rated the overall appearance of their target nail on a 4-point scale. They also assessed whether thickening, discoloration, brittleness, and softness of the target nail had improved since baseline. Adverse events (AEs) that occurred between the first application of K101-03 and the end of treatment were recorded and categorized according to severity and relationship to K101-03.
RESULTS
After 8 weeks of K101-03 treatment, 92.2% of patients (95% confidence interval [CI] 87.06-97.40) reported at least some improvement in the target nail. After 1 week of treatment, 78.3% of patients with onychomycosis (95% CI 68.53-87.99) reported at least some improvement in the target nail, and 55.1% of them reported that discoloration of their target nail had improved. Three patients reported a total of 5 AEs, none of which were judged to be related to K101-03.
CONCLUSIONS
In summary, K101-03 was well tolerated in patients with onychomycosis or nail psoriasis and rapidly improved their nails.
简介
甲真菌病和甲银屑病会令患者感到尴尬,因此改善受影响指甲的外观应该是治疗的短期关键目标之一。
方法
进行了一项为期 8 周的开放性、多中心研究,以评估含有丙二醇、甘油、尿素和乳酸的市售 K101-03 局部治疗药物是否能在 8 周内迅速改善受影响指甲的美观。患有甲真菌病(n=72)、银屑病(n=34)或两者皆有的成年患者(n=1)每天将 K101-03 涂抹于一个大脚趾甲或手指甲(“目标”指甲)一次,持续 8 周。在治疗期间和结束后,患者使用 4 分制评估目标指甲的整体外观。他们还评估了目标指甲的增厚、变色、脆性和变软情况是否自基线以来有所改善。记录并根据严重程度和与 K101-03 的关系对治疗期间首次应用 K101-03 至治疗结束期间发生的不良事件(AE)进行分类。
结果
K101-03 治疗 8 周后,92.2%(95%置信区间[CI]87.06-97.40)的患者报告目标指甲至少有一定程度的改善。治疗 1 周后,78.3%(95%CI68.53-87.99)的甲真菌病患者报告目标指甲至少有一定程度的改善,其中 55.1%的患者报告目标指甲的变色情况有所改善。有 3 名患者共报告了 5 起 AE,均未被判断与 K101-03 相关。
结论
总之,K101-03 在患有甲真菌病或甲银屑病的患者中耐受良好,且迅速改善了他们的指甲外观。